BRIEF-Arcturus Therapeutics Q3 Net Income USD -7.414 Million
Nov 05 (Reuters) - Arcturus Therapeutics Q3 basic EPS USD -0.26.
Related stories
Imperial Metals 3Q EPS C$0.00 >III.T
L impact | EARNINGS | Nov 05, 2026, 10:15 PM UTC
Comstock Holding 3Q EPS 6c >CHCI
L impact | EARNINGS | Nov 05, 2026, 10:15 PM UTC
Pembina Pipeline Reports Third-Quarter Adjusted EPS
M impact | EARNINGS | Nov 05, 2026, 10:14 PM UTC
Americold 3Q 2026: Revenue $691.56M, EPS $2.38 — 10-Q Summary
Americold’s third-quarter revenue rose modestly year over year, while earnings improved sharply, moving from a loss to income. Results included a large gain from the formation of t
L impact | EARNINGS | Nov 05, 2026, 10:13 PM UTC
American Coastal Insurance 3Q 2026: Revenue $70.7M, EPS $0.4 — 10-Q Summary
American Coastal Insurance's third-quarter revenue and net income declined year over year as net premiums earned fell amid softer market pricing. Lower loss and general and adminis
L impact | EARNINGS | Nov 05, 2026, 10:13 PM UTC
Cryoport 3Q 2026: Revenue $50.22M, EPS ($0.25) — 10-Q Summary
Cryoport’s third-quarter revenue rose 13.5% year over year, while its net loss widened. Growth in Life Sciences Services and Products revenue was partly offset by higher costs; inc
L impact | EARNINGS | Nov 05, 2026, 10:13 PM UTC